https://ift.tt/2wwdHAe These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them? Repatha (Drug), Drugs (Pharmaceuticals), Health Insurance and Managed Care, Cholesterol Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices. GINA KOLATA https://ift.tt/2DL1X0A October 2, 2018 at 05:30AM